Polygenic risk score analysis of pathologically confirmed Alzheimer disease

Annals of Neurology

Volumn 82, Issue 2, 2017, Pages 311-314

  Escott Price, Valentina ^a   Myers, Amanda J ^b   Huentelman, Matt ^c   Hardy, John ^d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AREA UNDER THE CURVE; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MULTIFACTORIAL INHERITANCE; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; AREA UNDER CURVE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MODELS, GENETIC; MULTIFACTORIAL INHERITANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT;

EID: 85027880812     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24999     Document Type: Article

References (11)

1. Escott-Price V, Sims R, Bannister C, et al. Common polygenic variation enhances risk prediction for Alzheimer's disease. Brain 2015;138(pt 12):3673–3684.
2. Karran E, Hardy J. A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann Neurol 2014;76:185–205.
3. Majounie E, Abramzon Y, Renton AE, et al. Repeat expansion in C9ORF72 in Alzheimer's disease. N Engl J Med 2012;366:283–284.
4. Corneveaux JJ, Myers AJ, Allen AN, et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 2010;19:3295–3301.
5. Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies via imputation of genotypes. Nat Genet 2007;39:906–913.
6. Lambert JC, Ibrahim-Verbaas CA, Harold D, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013;45:1452–1458.
7. Lee SH, Yang J, Chen GB, et al. Estimation of SNP heritability from dense genotype data. Am J Hum Genet 2013;93:1151–1155.
8. Escott-Price V, Shoai M, Pither R, et al. Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease. Neurobiol Aging 2017;49:214.e7–214.e11.
9. Jones L, Holmans PA, Hamshere ML, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One 2010;5:e13950.
10. Matarin M, Salih DA, Yasvoina M, et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep 2015;10:633–644.
11. Huang KL, Marcora E, Pimenova AA, et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease. Nat Neurosci 2017;20:1052–1061.